EQS-Adhoc: Fresenius Medical Care AG : Change in CEO – Shervin J. Korangy Succeeds Helen Giza
|
EQS-Ad-hoc: Fresenius Medical Care AG / Key word(s): Personnel decisions / Executive Board Bad Homburg, (October 7, 2026) – The Supervisory Board of Fresenius Medical Care AG unanimously resolved today to appoint Shervin J. Korangy as Chairman of the Management Board effective October 12, 2026. Shervin J. Korangy has resigned from his position as a member of the Company's Supervisory Board. Helen Giza, the long-serving Chairwoman of the Management Board, will leave the Company with effect from the end of October 11, 2026. The Supervisory Board thanks Helen Giza for her service to the Company.
Contact: Dr. Dominik K. Heger Executive Vice President Global Head of Investor Relations, Market & Competition, Sustainability & Head of Investor Relations Fresenius Medical Care AG Else-Kroener-Strasse 1, 61352 Bad Homburg v.d. Hoehe, Germany P +49 6172 2685822 Dominik.Heger@FreseniusMedicalCare.com www.FreseniusMedicalCare.com End of Inside Information
07-Oct-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Fresenius Medical Care AG |
| Else-Kröner-Straße 1 | |
| 61352 Bad Homburg | |
| Germany | |
| Phone: | +49 (0) 6172- 609 2525 |
| Fax: | +49 (0) 6172- 609 2301 |
| E-mail: | ir@freseniusmedicalcare.com |
| Internet: | www.freseniusmedicalcare.com |
| ISIN: | DE0005785802 |
| WKN: | 578580 |
| Indices: | DAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX; NYSE, Luxembourg Stock Exchange |
| LEI Code: | 549300CP8NY40UP89Q40 |
| EQS News ID: | 2412002 |
| End of Announcement | EQS News Service |
|
|
2412002 07-Oct-2026 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | ||
| Sales1 | 17.859,06 | 17.618,69 | 19.398,02 | 19.453,62 | 19.335,91 | 19.627,60 | 19.710,00 | |
| EBITDA1,2 | 4.090,31 | 3.475,97 | 3.350,00 | 3.121,41 | 3.134,65 | 3.327,45 | 3.380,00 | |
| EBITDA-Margin3 | 22,90 | 19,73 | 17,27 | 16,05 | 16,21 | 16,95 | 17,15 | |
| EBIT1,4 | 2.304,41 | 1.852,29 | 1.511,76 | 1.369,44 | 1.392,39 | 1.827,04 | 1.845,00 | |
| EBIT-Margin5 | 12,90 | 10,51 | 7,79 | 7,04 | 7,20 | 9,31 | 9,36 | |
| Net Profit (Loss)1 | 1.435,83 | 1.219,03 | 894,33 | 732,46 | 740,87 | 1.191,27 | 1.230,00 | |
| Net-Margin6 | 8,04 | 6,92 | 4,61 | 3,77 | 3,83 | 6,07 | 6,24 | |
| Cashflow1,7 | 4.233,16 | 2.489,50 | 2.167,38 | 2.628,80 | 2.386,14 | 2.681,00 | 2.740,00 | |
| Earnings per share8 | 3,96 | 3,31 | 2,30 | 1,70 | 1,83 | 3,36 | 3,29 | |
| Dividend per share8 | 1,34 | 1,35 | 1,12 | 1,19 | 1,44 | 1,49 | 1,54 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: PricewaterhouseCoopers
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Fresenius Medical Care | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| 578580 | DE0005785802 | AG | 10.866,13 Mio € | 02.10.1996 | Halten | 9F2C6J8F+2R |
| PE 2027e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 11,69 | 16,51 | 0,71 | 11,80 | 0,84 | 4,05 | 0,55 |
|
Dividend '2024 in € |
Dividend '2025 in € |
Dividend '2026e in € |
Div.-Yield '2026e in % |
| 1,44 | 1,49 | 1,54 | 3,81% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 21.05.2026 | 05.05.2026 | 04.08.2026 | 03.11.2026 | 13.03.2026 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| +1,52% | +2,33% | -0,74% | -12,97% | +85,43% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
